Measuring the Incidence of Candida Bloodstream Infections and Tracking Antifungal Drug Resistance
Although Candida is the fourth most common cause of bloodstream infections among U.S. hospital patients, information about this infection in large populations is scarce. Results from this project will allow us to learn more about common Candida infections in many different types of patients, as well as whether antifungal drug resistance is changing.
The EIP HAI Candidemia surveillance project will:
- Determine how many Candida bloodstream infections happened in these areas
- Describe people at risk for Candida bloodstream infections
- Discover which types of Candida cause illness
- Reveal trends of drug resistance
Data are expected to begin to be published in 2012.